ÂÜÀòÂÒÂ×

Mark Nedelman is an experienced professional in the biomedical and therapeutic sectors, holding positions such as Board Trustee at XenoTherapeutics and Consultant at CeleCor Therapeutics. Mark has also served as a New Business Development Consultant for Bioculture Group and as CEO of Biomedical Research Models, Inc., dba Biomere. Additionally, Mark is the President & CEO of EKAM IMAGING, INC. Academically, Mark earned an MBA from Northeastern University in 2007 and holds a Master of Science in Biology from the University of Cincinnati, obtained in 1983.